SAB Biotherapeutics, Inc. (NASDAQ:SABSW – Get Rating) was the recipient of a large decrease in short interest in the month of May. As of May 31st, there was short interest totalling 8,500 shares, a decrease of 50.0% from the May 15th total of 17,000 shares. Based on an average daily volume of 25,900 shares, the […]